Why the study?
Does admission hyperglycemia predict worse short and long-term outcomes in patients after acute myocardial infarction?
Does admission hyperglycemia predict worse short and long-term outcomes in patients after acute myocardial infarction?
Admission hyperglycemia independently predicts worse outcomes in AMI patients, with distinct prognostic thresholds depending on baseline diabetes status.
Admission hyperglycemia may aid AMI risk stratification by diabetes status; leaves open whether targeting specific thresholds improves outcomes.
The inflection points of FBG level for poor prognosis were 5.60 mmol/L for patients without diabetes and 10.60 mmol/L for patients with diabetes. Admission hyperglycemia was identified as an independent predictor of worse short and long-term outcomes in AMI patients, with or without diabetes. These findings should be explored further.
No takes yet. Share an insight, caveat, or question.
Upur et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: